期刊文献+

铜绿假单胞菌疫苗研究进展 被引量:2

Advances in the research of Pseudomonas aeruginosa vaccines
原文传递
导出
摘要 铜绿假单胞菌(Pseudomonas aeruginosa,Pa)是一种重要的条件致病菌,能引起严重的医院内感染和社区获得性感染。随着抗药性菌株尤其是多重抗药性菌株的出现,使得采用有效疫苗来预防Pa感染变得更加重要。此文概述了多糖疫苗、鞭毛疫苗、外膜蛋白疫苗、灭活全菌体疫苗、减毒活疫苗、菌毛疫苗以及DNA疫苗的研制近况。 Pseudomonas aeruginosa (Pa) is an important opportunistic pathogen, which can cause hospital- and community-acquired infections. With the emergence of antibiotic-resistant Pa strains, especially multiple-antibiotic-resistant Pa strain, using efficacious vaccine to prevent Pa infection becomes more imorptant. This review summarizes the present state of resesrch and development of Pa vaccines, including polysaccharide vaccine, flagella vaccine, outer membrane protein vaccine, killed whole cell vaccine, live attenuated vaccine, pili vaccine and DNA vaccine.
出处 《国际生物制品学杂志》 CAS 2010年第1期33-37,共5页 International Journal of Biologicals
关键词 假单胞菌 铜绿 疫苗 免疫接种 主动 Pseudomonas aeruginosa Vaccines Immunization, active
  • 相关文献

参考文献45

  • 1Cryz SJ Jr, Furer E, Que JU. Synthesis and characterization of a Pseudomonas aeruginosa alginate-toxin A conjugate vaccine [J].Infect Immun, 1991, 59( 1 ) :45-50.
  • 2Theilacker C, Coleman FT, Mueschenbom S, et al. Construction and characterization of a Pseudomonas aeruginosa mueoid exopolysaccharide-alginate conjugate vaccine [ J ]. Infect Immun, 2003, 71 (7) :3875-3884.
  • 3Kashef N, Behzadian-Nejad Q, Najar-Peerayeh S, et al. Synthesis and characterization of Pseudomonas aeruginosa alginate-tetanus toxoid conjugate [J]. J Med Microbiol, 2006, 55(Pt 10) : 1441-1446.
  • 4陆淼泉,王复甦,尹秀.铜绿假单胞菌胞外粘液多糖结合菌苗的实验研究[J].中国人兽共患病杂志,2001,17(3):19-21. 被引量:6
  • 5Cryz SJ Jr, Sadoff JC, Cross AS, et al. Safety and immunogenicity of a polyvalent Pseudomonas aeruginosa O-polysaccharidetoxin A vaccine in humans [ J]. Antibiot Chemother, 1959, 42: 177-183.
  • 6Cryz SJ Jr, Wedgwood J, Lang AB, et al. Immunization of non- colonized cystic fibrosis patients against Pseudomonas aeruginosa [J]. J Infect Dis, 1994, 169(5) :1159-1162.
  • 7Schaad UB, Lang AB, Wedgwood J, et al. Safety and immunogenicity of Pseudomonas aeruginosa conjugate A vaccine in cystic fibrosis [ J]. Lancet, 1991,338 (8777) : 1236-1237.
  • 8Lang AB, Rudeberg A, Schoni MH, et al. Vaccination of cystic fibrosis Patients against Pseudomonas aeruginosa reduces the proportion of Patients infected and delays time to infection [J]. Pediatr Infect Dis J, 2004, 23(6) :504-510.
  • 9Dasgupta N, Wolfgang MC, Goodman AL, et al. A four-tiered transcriptional regulatory circuit controls flagellar biogenesisin Pseudomonas aeruginosa [ J ]. Mol Microbiol, 2003, 50 ( 3 ) : 809- 824.
  • 10Prince A. Flagellar activation of epithelial signaling [ J ]. Am J Respir Cell Mol Biol, 2006, 34(5) :548-551.

二级参考文献15

  • 1[1]Roilides E,Butler KM,Husson RN,et al.Pseudomonas infection in children with human immunodeficiency virus infection[J].Pediatr Infect Dis,1992,11(7):547.
  • 2[2]Marty N,Dournes JL,Chabanon G,et al.Influence of nutrient media on the chemical composition of the exopolysaccharide from mucoid and non-mucoid Pseudomonas aeruginosa[J].FEMS Microbiol lett,1992,77 (1-3):35.
  • 3[3]Marty N,Pasquier C,Dournes JL,et al.Effects of characterized Pseudomonas aeruginosa exopolysacharides on adherence to human tracheal cells[J].J Med Microbiol,1998,47(2):129.
  • 4[4]Meluleni GJ,Grout M,Evans DJ,et al.Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by antibodies produced during chronic lung infection in cystic fibrosis[J].J Immunol,1995,155(4):2029.
  • 5[5]Feavers IM,Suker J,Mckenna AJ,et al.Molecular analysis of the serotyping antigen of Neisseria Meningitidis[J].Infect Immun,1992,60 (9):3620.
  • 6[6]Hatano K,Boisot S,DesJardins D,et al.Immunogenic and antigenic properties of a hepavalent high-molecular-weight o-polysaccharide vaccine derived from Pseudomonas aeruginosa[J].Infect Immun,1994,62 (9):3608.
  • 7[7]Staczek J,Gilleland HE Jr,Gilleland LB,et al.A chimeric influenza virus expressing an epitope of outermembrane protein F of Pseudomonas aeruginosa affords protection against challenge with P.aeruginosa in a murine model of chronic pulmonary infection[J].Infect Immun,1998,66(8):3990.
  • 8[8]Matsumoto T,Tateda K,Furuya N,et al.Efficacies of alkaline protease、elastase and exotoxin A toxoid vaccine against gut-derived Pseudomonas aeruginosa sepsis in mice[J].J Med Microbiol,1998,47(4):303.
  • 9[9]Pier GB,Small GJ,Warren HB.Protection against mucoid Pseudomonas aeruginosa in rodent model of endobronchial infection[J].Science,1990,249(4968):537.
  • 10[10]Pier GB,DesJardin D,Grout M,et al.Human immune response to Pseudomonas aeruginosa mucoid exopolysaccharide (Alginate) vaccine[J].Infect Immun,1994,62(9):3972.

共引文献5

同被引文献9

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部